Format

Send to

Choose Destination
BMJ. 2017 May 2;357:j2062. doi: 10.1136/bmj.j2062.

Conditional approval of medicines by the EMA.

Author information

1
IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy rita.banzi@marionegri.it.
2
IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
PMID:
28465401
DOI:
10.1136/bmj.j2062

Conflict of interest statement

Competing interests: We have read and understood BMJ policy on declaration of interests and have no relevant interests to declare.

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center